Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
59.00    2.50 (4.42%)
Bid:
58.00
Ask:
60.00
Spread: 2.00 (3.448%)
Market Cap: £55.91m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Trading Update

21 Jan 2021 07:00

RNS Number : 3862M
Panoply Holdings PLC (The)
21 January 2021
 

This announcement contains inside information

 

 

21 January 2021

 

The Panoply Holdings PLC

("The Panoply", or the "Group")

 

Trading update

 

Strong progress leads to performance significantly ahead of expectations

 

The Panoply Holdings PLC (AIM: TPX), the technology-enabled services group focused on digital transformation, announces an update on trading for the nine months to 31 December 2020 and full year outlook.

 

The Group is pleased to report a successful Q3 FY21 in which it achieved £15.0m of new contract wins. As a result of these wins, together with general business performance, the Board now expects the Group to report FY21 revenue in excess of £47.5m and adjusted EBITDA in excess of £6.3m (on a post-IFRS 16 basis).

 

This success in winning new business reflects the significant operational developments the Group made in calendar 2020, including an expanded reach into the healthcare sector and the establishment of its two full-service brands, FutureGov and Foundry4, alongside the continuing hard work and commitment of its staff throughout the pandemic.

 

Looking ahead to the final quarter, the Group continues to see an ongoing demand for digital transformation across the public and private sectors and looks forward to capitalising upon these opportunities.

 

Neal Gandhi, CEO of The Panoply commented:

 

"We're delighted to report on another quarter of strong trading which has left us tracking in line to significantly exceed our expectations for the full year to 31 March 2021. The benefits of having two full-service brands in place are becoming increasingly clear, supporting our competitive positioning. In addition, our presence in the health sector, augmented through the acquisition of Difrent, continues to drive growth.

 

"With this in mind, we look to the final quarter and the new financial year with confidence that our offering as a digitally-native, agile group will continue to be compelling for existing and prospective customers.

 

"I would like to reiterate my thanks to all of our staff for their ongoing commitment and dedication to delivering a first-class service to our clients, despite the external pressures of national lockdowns and disruption to daily life."

 

 

The person responsible for this announcement is Oliver Rigby, CFO.

 

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Joint Broker)

 

Via Alma PR

 

 

+44 (0)207 710 7600

Fred Walsh

Alex Price

 

 

Dowgate Capital Limited

(Joint Broker)

James Serjeant

David Poutney

 

 

+44 (0)203 903 7715

Alma PR

(Financial PR)

Susie Hudson

Josh Royston

Harriet Jackson

panoply@almapr.co.uk

+44 (0)203 405 0209

 

 

About The Panoply

 

The Panoply is a technology-enabled services group, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

The Group is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c.70% of its client base representing the public sector and c.30% representing the commercial sector.

More information is available at www.thepanoply.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFVILIIIFIL
Date   Source Headline
1st Jun 20267:00 amRNSTPXimpact announces £16m contract with the MoJ
11th May 20267:00 amRNSShare Incentive Plan
22nd Apr 20267:00 amRNSFull Year Trading Update and Notice of Results
17th Apr 20264:17 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSShare Incentive Plan
20th Mar 20267:00 amRNSShare Incentive Plan
24th Feb 20267:00 amRNSQ3 Trading Update: EBITDA guidance Upgrade
17th Feb 20267:00 amRNSContract Uplift
12th Feb 20267:01 amRNSTPXimpact announces £39m Contract with DEFRA
12th Feb 20267:00 amRNSShare Incentive Plan
11th Feb 20267:00 amRNSTPXimpact announces £22m NHS England contract
9th Jan 20267:00 amRNSShare Incentive Plan
9th Dec 20257:00 amRNSShare Incentive Plan
8th Dec 20255:19 pmRNSHolding(s) in Company
2nd Dec 20252:45 pmRNSExercise of Options, PDMR, & Total Voting Rights
2nd Dec 20257:00 amRNSUnaudited Interim Results
24th Nov 20257:30 amRNSAppointment of Nominated Adviser and Broker
14th Nov 20257:00 amRNSShare Incentive Plan
5th Nov 20257:00 amRNSFirst Half Update & Notice of Results
14th Oct 20255:29 pmRNSShare Incentive Plan
25th Sep 20254:37 pmRNSResult of AGM
9th Sep 20257:00 amRNSShare Incentive Plan
8th Sep 20255:25 pmRNSExercise of Options & PDMR Dealings
8th Sep 20253:27 pmRNSNotification of Major Holdings
5th Sep 202512:37 pmRNSIssuance of Shares & Total Voting Rights
22nd Aug 20257:00 amRNSNotice of AGM
21st Aug 20257:00 amRNSChange of Auditor
12th Aug 20256:05 pmRNSReplacement: FY25 & FY26 Share Awards
11th Aug 20257:00 amRNSPosting of Annual Report
4th Aug 20259:24 amRNSReplacement: FY25 & FY26 Share Awards
4th Aug 20257:00 amRNSFY25 & FY26 Long-Term Incentive Share Award
30th Jul 20257:00 amRNSDebt Facility Renewal Update
14th Jul 20257:00 amRNSAppointment of non-executive director
10th Jul 20257:00 amRNSShare Incentive Plan
24th Jun 20257:00 amRNSUnaudited preliminary results
16th Jun 20259:00 amRNSNotice of Results
12th Jun 20251:17 pmRNSShare Incentive Plan
14th May 20257:00 amRNSTrading Update and Contract Wins
22nd Apr 20257:00 amRNSResignation of Non-Executive Director
11th Apr 20257:00 amRNSShare Incentive Plan
12th Mar 20257:00 amRNSShare Incentive Plan
28th Feb 20253:26 pmRNSChange of Registered Office Address
12th Feb 20257:00 amRNSShare Incentive Plan
6th Feb 20257:00 amRNSQ3 Trading Update and Revised Outlook
3rd Feb 20257:00 amRNSConfirmation of CFO Appointment
15th Jan 20257:00 amRNSShare Incentive Plan
18th Dec 20247:00 amRNSDirectorate Change - Group CFO retirement
11th Dec 20247:00 amRNSShare Incentive Plan
5th Dec 20247:00 amRNSExercise of Options and PDMR Dealings
28th Nov 20247:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.